Biotech ETFs Face Crucial FDA Week as Drug Catalysts Loom – State Street SPDR S&P Biotech ETF (ARCA:XBI)


XBI and IBB lagged SPY and QQQ as two FDA decisions and fresh Alzheimer’s and obesity-drug data put biotech ETFs in focus.

Leave a Reply

Your email address will not be published. Required fields are marked *